Ann Henry

Has grant

Associate Professor in Clinical Oncology

University of Leeds School of Medicine

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Medical Imaging Medical Imaging professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ann Henry is an Associate Professor in Clinical Oncology at the University of Leeds School of Medicine, UK. Her research focuses on radiotherapy techniques for prostate cancer, including the use of MRI radiomics and genetic signatures to predict patient outcomes. Additionally, she has conducted qualitative studies on patient perspectives regarding cancer treatment and has contributed to guidelines in the field of brachytherapy.

Recent Grants

Grant: Open

Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC)

Open Date: 2022-09-01

Close Date: 2031-02-01

Grant: Close

Leeds Clinical Trial Research Unit Fellowship- developing a future chief investigator of technical radiotherapy

Open Date: 2022-04-01

Close Date: 2025-03-01

Grant: Close

MRI scans with respiratory Immobilisation to Contour Radiotherapy Organs at risk using oral Contrast of Hypo or hyper intense fluids Including the Patient perSpective: The MICROCHIPS study.

Open Date: 2021-07-01

Close Date: 2025-06-30

Grant: Close

CRUK Radiation Research Centre of Excellence at the University of Leeds

Open Date: 2019-11-01

Close Date: 2024-10-01

Grant: Close

Effective clinical cancer treatment, care and management for people with comorbid cancer and dementia: understanding population demographics and intervention priorities and outcomes (CanDem-Int)

Open Date: 2018-05-01

Close Date: 2019-07-31

Articles (28)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (18)

Claire Hulme

Head of Department & Professor

University of Exeter

UNITED KINGDOM

Ann Henry

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (28)

Combining MRI radiomics, hypoxia gene signature score and clinical variables for prediction of biochemical recurrence-free survival after radiotherapy in prostate cancer

Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomised Controlled Trial

The POINTER-PC Study-determining Optimal Radiotherapy for Pelvic Nodal Recurrence in Prostate Cancer

1427 Patient perspectives of liver SABR: a qualitative study.

2920 A hypoxia-based prognostic Bayesian network for high-risk prostate cancer patients treated with radiotherapy

Corrigendum to “GEC-ESTRO ACROP prostate brachytherapy guidelines” [Radiother Oncol. 2022; 167: 244–251]

Non-medicinal oral contrast in upper abdominal MRI for MR-guided radiotherapy: A scoping review

Use of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Nodal Staging in Prostate Cancer and Tailoring of Treatment: A Continuing Conundrum

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

Automated confidence estimation in deep learning auto‐segmentation for brain organs at risk on MRI for radiotherapy

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent

Dosimetric impact of contour editing on CT and MRI deep‐learning autosegmentation for brain OARs

125: Proof-of-concept study to identify potential non-medicinal oral contrasts for MR-guided radiotherapy

594: An automated assessment pipeline to identify prostate treatments that need adaptive radiotherapy.

Hypoxia-associated gene signatures are not prognostic in high-risk localised prostate cancers undergoing androgen deprivation therapy with radiotherapy

Geometric evaluations of CT and MRI based deep learning segmentation for brain OARs in radiotherapy.

ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer

Acute Toxicity of Hypofractionated and Conventionally Fractionated (Chemo)Radiotherapy Regimens for Bladder Cancer: an Exploratory Analysis from the RAIDER Trial

Online Symptom Monitoring During Pelvic Radiation Therapy: Randomized Pilot Trial of the eRAPID Intervention

Evaluation of the impact of teaching on delineation variation during a virtual stereotactic ablative radiotherapy contouring workshop

MRI-guided Pelvic Radiation Therapy: A Primer for Radiologists

The feasibility of patient reported outcome measures for the care of penile cancer

Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP)

Prognostic factors for patients with anal cancer treated with conformal radiotherapy—a systematic review

Characteristics and general practice resource use of people with comorbid cancer and dementia in England: a retrospective cross-sectional study

Marginal Gains and Clinical Trials – Improving and Influencing Practice

Collaborators (18)

Claire Hulme

Louise Murray

Ian S Dayes

robert huddart

Eleanor Bryant

Andrew Scarsbrook

Peter Hoskin

Hitesh Mistry

Michelle Collinson

Robert Bristow

Alexandra Gilbert

Ananya Choudhury

David Sebag-Montefiore

David Buckley

Catharine West

Cynthia Eccles

Peter Branney

Kelechi Njoku

Make your next move.